As competitors have launched their first pulsed field ablation devices in the U.S., Abbott CEO Robert Ford told investors ...

Stereotaxis CEO David Fischel said the precision, stability and safety profile of robotics are a good fit for pulsed field ...

Medical device firms discussed privacy, regulations and prioritizing projects as AI becomes more prevalent in the industry.

CEO Joaquin Duato said the spinout will help the healthcare giant focus on medtech areas with higher growth and margins, such ...

Investment in 2025 has reached $9.9 billion, exceeding the $8.4 billion that was raised through the third quarter last year, ...

Six takeaways from the CMS administrator’s appearance at a D.C. think tank Monday — including who’s set to be the next ...

With positive trial results in urology and hernia repair already under its belt, the company is getting closer to taking on ...

Implementing artificial intelligence requires significant human labor and technical expertise, threatening to create a ...

The FDA cleared AI and imaging updates for Intuitive’s lung biopsy robot. Elsewhere, Horizon completed the first cataract ...

The company plans to launch the device in Europe late next week, providing competition for AtriCure’s AtriClip product.

Michelle Tarver, director of the Center for Devices and Radiological Health, and other center officials attended virtually as ...

Executives from Stryker and Johnson & Johnson are on the hunt for deals, despite a turbulent environment, they said at ...